Company Overview of Purdue Pharma Inc.
Purdue Pharma Inc. researches, develops, and manufactures over the counter and prescription medicines for pain management, attention deficit hyperactivity, and gastrointestinal disorders for patients and healthcare professionals in Canada. Its over the counter products include laxatives, decongestant, and antiseptics for the preparation of skin prior to surgery and injections. The company’s prescription medication comprises central nervous system stimulants, opioid analgesics, opioid antagonists, and bronchodilators. It also engages in the research in the field of drug delivery for the treatment of respiratory diseases, infection control, and urinary incontinence. The company was founded in ...
575 Granite Court
Pickering, ON L1W 3W8
Founded in 1956
Key Executives for Purdue Pharma Inc.
Chief Executive Officer and President
Chief Financial Officer and Executive Vice President
Chief Executive Officer of Purdue Pharma L.P. and President of Purdue Pharma L.P.
Executive Vice President of Finance
Executive Vice President for Due Diligence & Integration Management
Compensation as of Fiscal Year 2016.
Purdue Pharma Inc. Key Developments
Medical Developments International Limited Signs Exclusive Licensing and Distribution Agreement with Purdue Pharma Canada for Penthrox® in Canada
Sep 12 16
Medical Developments International Limited announced that it has reached an exclusive distribution and licensing agreement with Purdue Pharma (Canada) for Penthrox® (Low-Dose Methoxyflurane) Inhaler in Canada. Purdue Canada will pay MDI up to CAD 3 million through a combination of upfront, milestone, and success basedpayments.
Helsinn Group Signs Agreement with Purdue Pharma Canada
Apr 27 16
Helsinn Group signed an agreement with Purdue Pharma Canada, for the distribution and licensing of Akynzeo. Akynzeo is the oral fixed combination of netupitant and palonosetron and is used to prevent chemotherapy-induced nausea and vomiting (CINV). As per the terms of the deal, Helsinn will continue to carry out the clinical development activities, along with the manufacturing and supply of Akynzeo. Purdue Pharma will enjoy the rights to registration, promotion, marketing, sales and distribution of Akynzeo across Canada.
John Sebben Joins Purdue Pharma Canada as Vice President, Manufacturing Operations
Apr 11 16
John Sebben has joined Purdue Pharma Canada as Vice President, Manufacturing Operations, effective April 11, 2016. John brings to Purdue more than 20 years of Canadian and International supply chain and manufacturing operations leadership experience, having worked at a number of premier companies including: GlaxoSmithKline, Apotex, Teva Canada, Pharmascience, Biovail and most recently, Patheon, where he held the role of Vice President, North American Supply Chain.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|